The NGS Oncology Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the NGS Oncology Market?
The market size of the NGS oncology sector has seen a swift increase recently. A growth from $17.36 billion in 2024 to $19.39 billion in 2025 is expected, with a Compound Annual Growth Rate (CAGR) of 11.7%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the NGS Oncology Industry?
The NGS oncology global market is projected to reach a size of $29.86 billion in 2029, with a compound annual growth rate (CAGR) of 11.4%.
Download Your Free Sample of the 2025 NGS Oncology Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the NGS Oncology Market?
The key drivers in the ngs oncology market are:
• Expansion of companion diagnostics in the field of oncology
• A marked increase in the prevalence of cancer cases globally
• Significant increase in both government and healthcare sector investments
• Growth in clinical applications of NGS in oncology
• Rising popularity and application of targeted cancer therapies
Global Market Segmentation: Identifying Major NGS Oncology Industry Segments
The NGS oncology market covered in this report is segmented –
1) By Sequencing Technology: Targeted Sequencing, Genomics, Transcriptomics, Epigenomics
2) By Offering: Platform, Kits, Services
3) By Workflow: Pre-Sequencing, Sequencing, Data Analysis
4) By Application: Genetic Screening, Hereditary Genetic Testing, Hematological Malignancies, Solid Tumors, Other Applications
5) By End User: Hospitals And Clinics, Clinical Research Organizations (CROs), Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users
Pre-order the 2025 NGS Oncology Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the NGS Oncology Market?
The key trends in the ngs oncology market are:
• There is an emerging trend of integrating artificial intelligence and machine learning in the NGS oncology market.
• Advancements in single-cell sequencing are shaping the future of the market.
• The market is witnessing a trend in the development of enhanced sequencing platforms.
• There is a notable trend towards advancements in liquid biopsy technology.
Who Are the Top Competitors & Leading Players in the NGS Oncology Market?
Major players in the ngs oncology market are:
• Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Agilent Technologies Inc.
• Eurofins Scientific SE
• Illumina Inc.
• Qiagen N.V.
• Tecan Trading AG
• Myriad Genetics
• Takara Bio Inc.
• Beijing Genomics Institute (BGI)
• Caris Life Sciences
• Foundation Medicine
• Paradigm Diagnostics
• Pacific Bioscience
• Horizon Discovery Group plc
• Creative-Biolabs
• Xcelris Labs Ltd.
• Partek Inc.
• 4baseCare
• SciGenom Labs Pvt. Ltd.
Regional Dominance: Which Area Leads the Global NGS Oncology Market?
North America was the largest region in the NGS oncology market in 2024
